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Objective: To assess the adherence of physiotherapists to the study protocol and the occurrence 
of contamination bias during the course of a randomized controlled trial with a recruitment 
period of 2 years and a 1-year follow-up (COPE-II study).
Study design and setting: In the COPE-II study, intervention patients received a   standardized 
physiotherapeutic reactivation intervention (COPE-active) and control patients received usual 
care. The latter could include regular physiotherapy treatment. Information about the   adherence 
of physiotherapists with the study protocol was collected by performing a single interview 
with both intervention and control patients. Patients were only interviewed when they were 
  currently receiving physiotherapy. Interviews were performed during two separate time periods, 
10 months apart. Nine characteristics of the COPE-active intervention were scored. Scores 
were converted into percentages (0%, no aspects of COPE-active; 100%, full implementation 
of COPE-active).
Results: Fifty-one patients were interviewed (first period: intervention n = 14 and control   
n = 10; second period: intervention n = 18 and control n = 9). Adherence with the COPE-active 
protocol was high (median scores: period 1, 96.8%; period 2, 92.1%), and large contrasts in 
scores between the intervention and control group were found (period 1: 96.8% versus 22.7%; 
period 2: 92.1% versus 25.0%). The scores of patients treated by seven physiotherapists who 
trained patients of both study groups were similar to the scores of patients treated by physio-
therapists who only trained patients of one study group.
Conclusion: The adherence of physiotherapists with the COPE-active protocol was high, 
remained unchanged over time, and no obvious contamination bias occurred.
Keywords: physiotherapy, guideline adherence, compliance, bias, randomized controlled trial, 
chronic obstructive pulmonary disease
Introduction
Chronic obstructive pulmonary disease (COPD) is a systemic disease characterized 
by the progressive development of irreversible airflow limitation, leading to impaired 
muscle strength and exercise capacity.1 Physiotherapeutic exercise programs given 
by specialized physiotherapists are a well-established part of the treatment of patients 
with COPD and are incorporated in rehabilitation programs,2,3 self-management 
programs4–6 and in near home rehabilitation programs.7 The reported effectiveness 
of these programs, however, varies considerably. Besides the program content, lack 
of adherence with the protocol by physiotherapists8 and occurrence of contamination 
bias may partly explain such variability in outcomes.
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Effectiveness of health interventions can be seriously 
harmed by incomplete and incorrect execution of protocols 
by health care providers.9 Within randomized controlled 
  trials assessment of protocol adherence is indicated, because 
p  rotocol nonadherence may be one of the explanations for 
diminished or negative study outcomes. Assessment of 
  adherence will give more insight in the delivery of the inter-
vention under study. Whereas assessments of physiothera-
pists’ guideline adherence have been reported before,10–14 
assessments of physiotherapist’s adherence with study 
protocols are rare.
Besides  protocol  adherence,  the  occurrence  of 
  contamination bias can harm the effectiveness of an 
intervention.15 This bias results from cross-exposure between 
study arms (eg, when a control group is [partly] exposed to 
the intervention of interest in a randomized controlled trial) 
and can occur especially if randomization is performed at 
the patient level.16 As a result of randomization at the patient 
level, health care providers with knowledge of the study 
intervention can be involved in the treatment of interven-
tion and control patients at the same time. This increases 
the risk of exchange of intervention elements. Evaluation 
of contamination bias may be advisable in randomized con-
trolled trials, since this bias can lead to a reduction of the 
intervention effect.16
In the COPE-II study, an intensive, standardized 
community-based physiotherapeutic exercise program 
(COPE-active) was evaluated.4 Evaluation of contamination 
bias was of particular interest in this trial because the control 
group received usual care, which in some cases included 
regular physiotherapy, and randomization was performed 
at the patient level. As a consequence, physiotherapists 
could treat patients of both the intervention group and the 
control group.
We have developed and applied a practical procedure to 
assess physiotherapists’ adherence and contamination bias 
in the COPE-II study. Because adherence and the amount 
of contamination bias may have changed during the study, 
the degree of adherence of physiotherapists with the COPE-
active protocol and the presence of contamination bias were 
evaluated during two separate periods within the COPE II-
study (May–August 2005 and July–September 2006).
Methods
The design, inclusion criteria, intervention and outcome of 
the COPE-II study have been described previously.4 In the 
COPE-II study 159 outpatients with COPD were recruited 
(November 2004–July 2006). The study was approved by the 
Medical Ethics Committee of Medisch Spectrum Twente, 
Enschede, The Netherlands.
All patients attended a self-management education 
course, but only patients of the intervention group partici-
pated in the COPE-active program for a maximum period 
of 11 months. This training period per patient was divided 
in two parts: a ‘compulsory’ 6-month and a subsequent 
optional, but recommended, 5-month period. After the first 
6-month period, patients had the opportunity to continue 
with the COPE-active program for another 5 months on a 
voluntary basis. Patients in the control group were allowed 
to receive regular physiotherapy as a part of their usual care 
treatment. Initiation of prescribed regular physiotherapy was 
also allowed.
The detailed content of the standardized COPE-active 
intervention has been described previously in an online 
  repository.4 The content of usual care physiotherapy can-
not be described precisely, because its frequency and 
content were not standardized and varied considerably 
between patients. Frequency of treatment ranged between 
1–3 s  essions per week and whereas most sessions were 
directed towards training of respectively exercise capacity 
and muscle strength, the type of exercises and intensity dif-
fered considerably.
All physiotherapists who participated in the COPE-II trial 
were working in private physiotherapy practices in catchment 
areas of the Department of Pulmonary Medicine of Medisch 
Spectrum Twente, a large teaching hospital in Enschede, 
The Netherlands. They had all attended a national COPD 
course prior to the COPE-II study and were experienced in 
caring for COPD patients. Before the start of the COPE-II 
study, physiotherapists had to participate in an additional 
three-session course (11 hours in total) to refresh their knowl-
edge about COPD in general and to standardize the content of 
the COPE-active-program. Physiotherapists were instructed 
to treat control patients according to the standards that were 
applied prior to the COPE II-study. So, physiotherapists were 
trained to use the new treatment, which they had to withhold 
knowingly, in the case of control patients.
Patients instead of physiotherapists were interviewed 
to avoid socially desirable responses by physiotherapists.17 
Interviews were performed by one of the two independent 
interviewers during two periods in the study: period 1, 
May–August 2005 and period 2, July–September 2006. 
Interviewers were not blinded for the study group alloca-
tion of patients. Patients who were receiving physiotherapy 
(either COPE-active or regular physiotherapy) during one of 
these periods were asked for an interview. The goal of the 
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interviews was to examine to what extent the COPE-active 
protocol was applied by their physiotherapists.
All patients were interviewed at home using identical, 
semistructured questionnaires. They were blinded for the pur-
pose of the study and were unaware of the intended content of 
the COPE-active protocol. To distinguish patient adherence 
from protocol adherence by the physiotherapists, patients 
were not asked what activities they were actually performing, 
but what they were instructed to do. A total of 34 questions 
were scored. Although the questions were open in nature, 
a dichotomous score was attributed: (0) “not performed 
according to the COPE-active protocol” or (1) “performed 
according to the COPE-active protocol.”
Thirty-four questions were classified in ten different cat-
egories describing the features of the COPE-active training. 
During the study it became clear that one category “the 
choice for duration or interval training” could not be validly 
determined by only interviewing patients. Therefore, it was 
decided to determine the COPE-active score with nine aspects 
(30 questions) (Table 1). Adding together all aspect scores led 
to an overall score per patient ranging from 0 (no exposure to 
any aspect of COPE-active) through 9 (full exposure to the 
COPE-active-protocol). Because it is reasonable to assume 
that after 6 months of physiotherapy, the therapy is no longer 
aimed at improving exercise capacity and muscle strength but 
at maintaining the improvements achieved, it was decided to 
leave the two aspects regarding structural increase in intensity 
of the exercises (aspect 4 and 7) out of the overall score for 
patients with physiotherapy after 6 months. Thus, in patients 
who had been training for more than 6 months at the time of 
the interview, the overall score ranged from 0–7. Finally, all 
overall scores were converted into percentages, so scores of 
patients receiving physiotherapy for different lengths of time 
could be compared: 0% (no aspects of COPE-active) through 
100% (full implementation of the COPE-active-protocol).
Data analysis
Data analyses were performed using SPSS software 
(version 12.0; SPSS Inc, Chicago, IL). Descriptive statistics 
were used to compare the scores of the two study groups 
at two different periods in time and the scores per physio-
therapist. Between-group differences were tested with the 
Mann–Whitney U test.
Results
In COPE-II 159 patients were included (COPE-active, 80; 
Control, 79). Sixty-seven patients (87.0%) participated in 
the COPE-active program. Twenty-five control patients 
(32.9%) received regular physiotherapy during the 12-month 
follow-up (Figure 1).
Fifty-three of the included 159 patients were receiving 
physiotherapy (COPE-active or regular physiotherapy) during 
one of the two study periods in which the interviews were 
performed. No appointment for an interview could be made 
with two patients (COPE-active, n = 1; regular physiotherapy, 
n = 1). Therefore, 51 patients were finally interviewed 
(period 1: COPE-active, n = 14; regular physiotherapy, n = 10; 
period 2: COPE-active, n = 18; regular physiotherapy, n = 9). 
The 51 patients were trained by 18 different physiotherapists, 
of whom 15 were participating in the COPE-II study.
Table 1 The nine aspects of the COPE-active program, with number of items per aspect, the score per item, and the maximum score 
per aspect
Aspect Description Number of items  
per aspect
Score  
per item
Maximum score   
per aspect
1 Frequency of physiotherapeutic sessions (twice a week in the  
first 6 months; once a week thereafter)
1 1 1
2 Duration of physiotherapeutic sessions (60 minutes) 1 1 1
3 Type of exercises in physiotherapeutic sessions 
(cycling, walking, walking stairs, lifting [optional: push/pull])
5 0.25 1*
4† Increasing intensity of exercises 5 0.25 1*
5 Number of exercise sessions at home per week (at least one) 1 1 1
6 Type of exercises at home (one strength exercise of the lower  
extremities + one strength exercise of upper extremities +  
one exercise for endurance training: walking or cycling)
7 0.14 1
7† Increasing intensity of exercises at home 7 0.14 1
8 Within muscle strength training session: three repeating series 2 0.5 1
9 Use of Borg scores 1 1 1
Total 30 9
Notes: *Extra exercises (aspect 3: push/pull; aspect 4: push/pull, rowing, etc) could be scored, resulting in a surplus value of 0.25. Final aspect score cannot exceed 1; †in 
patients receiving physiotherapy for more than 6 months these aspects have been excluded because they are no longer applicable.
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In both periods, patients in the COPE-active groups 
reported very high scores on protocol aspects (median 
scores 96.8% and 92.1%, respectively) (Figure 2). A small 
and nonsignificant reduction could be observed over time 
(P = 0.44). Combining scores of the two periods, all but 
two of the COPE-active patients scored between 80% and 
100%. The two patients scoring below 80% (78.7% and 
61.9%) were both trained in the second time period. In both 
periods there was a clear and significant difference between 
the COPE-active group (median scores 96.8% and 92.1%, 
respectively) and the group receiving regular physiotherapy 
(median scores 22.7% and 25.0%, respectively) (P , 0.001) 
(Figure 2).
In Figure 3 all the individual patients’ scores (n = 51) are 
linked to the corresponding 18 physiotherapists. No overlap 
in scores was detected between the COPE-active group and 
patients receiving regular physiotherapy. Seven physiotherapists 
(1, 4, 5, 6, 7, 11, and 12) trained patients of both study groups. 
The median scores of patients treated by these latter physio-
therapists (COPE-active: 91.7%, n = 17; regular physiotherapy: 
23.1%, n = 13) did not deviate significantly from the scores of 
patients treated by physiotherapists who only treated patients 
of one study group (COPE-active: 100.0%, n = 15; regular 
physiotherapy: 26.4%, n = 6; P . 0.05).
The contribution of the different aspects to the total 
scores of both study groups for two subsamples (patients 
with ,6 months physiotherapy and patients with .6 months 
physiotherapy at the time of the assessment for the current 
analyses) is presented in Figure 4. In both subsamples of 
COPE-active patients, all aspects contributed to the total 
score. In the regular physiotherapy group, the contribution 
of the different aspects to the score was less consistent 
over time.
Discussion
This study suggests that the COPE-active protocol was appro-
priately performed by the physiotherapists in patients of the 
COPE-active group, and that physiotherapists maintained 
this high level of adherence during the study. Furthermore, 
the difference between the scores of the COPE-active group 
and the group receiving regular physiotherapy was marked 
and did not diminish during the COPE II-study.
The main reasons for not achieving the maximum score 
of 100% in the COPD active group can be found in the 
scores regarding home work sessions. A plausible explana-
tion is that some physiotherapists did not give home exercise 
instructions. Another explanation might be bias introduced by 
patient report (ie, patient nonadherence). Patients can claim 
Randomization
COPE-active group: n = 80
Withdrawn: n = 3
Baseline measurement: n = 77 Baseline measurement: n = 76
– Co-morbidity; n = 2
– Too busy; n = 1
Withdrawn: n = 3
Not participating in
COPE-active: n = 7
Receiving COPE-active:
n = 67
1-year follow-up: n = 74 1-year follow-up: n = 68
Receiving regular physiotherapy:
n = 25
Interview period 1:
n = 14
Interview period 2:
n = 18
No appointment for
interview
n = 1
No COPE-active
during period
1 or 2
n = 34
Interview period 1:
n = 10
Interview period 2:
n = 9
No appointment for
interview
n = 1
No regular
physiotherapy
during period
1 or 2
n = 5
No regular
physiotherapy: n = 43
– Too busy; n = 1
– Death; n = 2
– Transport (n = 2)
– Too busy (n = 3)
– Disagreement with
  protocol (n = 1)
– Co-morbidity (n = 1)
Withdrawn: n = 8
– Too busy; n = 1
– Death; n = 2
– Failure to return; n = 4
– Co-morbidity; n = 1
– Co-morbidity; n = 1
– Too busy; n = 2
Withdrawn: n = 3
Control group: n = 79
Figure 1 Flow diagram of patient progress through the COPE II-study.
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that no instructions for exercise at home were given, because 
they did not act on these instructions. Interviewers have tried 
to create a noncondemning and confidential atmosphere by 
not asking questions about whether or not exercises were 
really performed to avoid these socially desirable answers. 
A final explanation might be found in individual patient 
characteristics that limit full implementation of a protocol 
(eg, frequency of COPD exacerbations, comorbidities).10
The adherence levels of physiotherapists in the COPE-
  active group are high compared with adherence levels 
reported in previously published studies.10–14 A study 
regarding an active implementation strategy in low back pain 
patients reported an overall adherence of 42%.10 A prospec-
tive cohort study among Dutch physiotherapists showed 
that adherence to the clinical guideline osteoarthritis of hip 
and knee varied between 46% and 100%.18 This difference 
in adherence is not surprising, though, as these two studies 
involved implementation interventions that typically aim 
to promote adoption of new treatment guidelines among a 
population of professionals. Our study included a selected 
sample of professionals who were motivated to participate 
in an effectiveness trial of an innovative treatment, 
and consequently can be regarded as adopters of this new 
treatment. Other explanations for the high adherence level 
of physiotherapists in our study may be the use of a thor-
ough training which was compulsory for physiotherapists, 
and the awareness among physiotherapists that there was a 
reasonable chance that the content of their treatment would 
be evaluated (quality control).
Exposure of patients in the usual care group to the COPE-
active treatment was largely limited to two aspects: “duration 
of physiotherapeutic session” and “type of exercises within 
physiotherapeutic sessions.” This was not unexpected 
because training aimed at improvement of exercise capacity 
in patients with COPD will frequently last 60 minutes and 
regularly incorporate walking and/or cycling. Therefore, 
these two aspects seemed not to be very unique for the COPE-
active program and retrospectively it can be concluded that 
they did not contribute to the contrast between COPE-active 
and regular physiotherapy. The negligible exposure of usual 
care patients to the other seven COPE-active aspects, as 
well as the low and relatively stable overall COPE-active 
score of these patients over time, underline the absence 
of   contamination bias. Moreover, the difference in scores 
between both study groups was as obvious in practices 
treating patients of both study groups, in which the risk 
of contamination would be higher, as in practices treating 
patients of only one of the two study groups.
The absence of contamination bias is probably a result 
of instructions given to physiotherapists prior to the study, 
namely to continue with treatment of control patients accord-
ing to standards they applied before they were trained in the 
Figure 2 The median, 25th and 75th percentile of total scores and outliers (*) of patients receiving regular physiotherapy and COPE-active in two different time periods 
within the COPE-II study.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
341
Process evaluation in a rctInternational Journal of COPD 2012:7
COPE-active protocol. As a result, physiotherapists may have 
avoided application of any COPE-active protocol-like strate-
gies that they would normally have applied. This may have 
enlarged the differences between the two study groups.
Previous studies have used procedures such as self-
report,12 individual patients’ forms,10,14 and patient 
registration software11 to assess physiotherapists’ adherence. 
Self-report of adherence may be subject to bias.19 We chose 
to interview patients instead of physiotherapists to avoid 
social desirability. Patients were blinded for the purpose 
of this study and were unaware of the detailed content of 
the COPE-active protocol. Therefore, it is unlikely that 
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Figure 3 Individual patient’s scores of the COPE-active group (○) and the group receiving regular physiotherapy (∆) per physiotherapist.
Notes: Seven physiotherapists (1, 4, 5, 6, 7, 11, and 12) trained patients of both study groups and three physiotherapists were not participating in the COPE-II study 
(13, 17, and 18). In four cases two patients trained by the same physiotherapist had exactly the same score (*).
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respondents in this study provided biased reports. It should 
be noted that the interviewers in this study were not blinded 
for the study group allocation of patients. So, interviewer 
bias (intentional or unintentional prompting by the inter-
viewer, which affects the patient’s response) might have 
occurred, but cannot explain the vast contrast between both 
study groups.
The results of this evaluation give more insight into the 
delivery of the COPE-active intervention in the COPE-II 
study. Many randomized controlled trials lack such a process 
evaluation, leading to a black box concerning the effective-
ness of the intervention. Especially in the case of negative 
effects, one has to be sure that the intervention was provided 
according to protocol and that the effect was not diluted due 
to contamination bias. The results of the evaluations described 
in this paper imply that the adherence of physiotherapists 
with the studied protocol was excellent. No obvious con-
tamination bias occurred and therefore did not influence the 
final COPE-II results.4 The method applied seems suitable to 
assess how well treatments (both experimental and control) 
are adhered to in RCTs.
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